MedTrace Logo

Flaxseed Consumption and Bone Metabolism in Postmenopausal Women.

NCT03036722 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 44

Last updated 2018-05-16

No results posted yet for this study

Summary

This proposed randomized double blinded, placebo-controlled, parallel trial; with two arms, in females aged 50-70 years, volunteers will be postmenopausal with a BMI between 25-35 kg/m2. This study aims to determine the benefits of phytoestrogen-rich flaxseeds on decreasing bone turnover in postmenopausal women aged over 50 years.

Conditions

  • Bone Loss, Age Realted
  • Post Menopausal

Interventions

OTHER

Flaxseed

Flaxseed is a member of the genus Linum in the family Linaceae. It is a food and fiber crop and it occurs in two basic varieties: brown and yellow or golden (also known as golden linseeds).

OTHER

Placebo control porridge

control porridge matched for energy and fat content.

Sponsors & Collaborators

  • University of Reading

    lead OTHER

Principal Investigators

  • Mike Proven, PhD · Ethics committee Co-ordinator

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
70 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-05-10
Primary Completion
2018-11-01
Completion
2018-11-01

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03036722 on ClinicalTrials.gov